Piperazine derivatives useful as CCR5 antagonists

Details for Australian Patent Application No. 2005202357 (hide)

Owner Schering Corporation

Inventors Laughlin, Mark A; Miller, Michael W; Steensma, Ruo; Josien, Hubert B; Smith, Elizabeth M; Vice, Susan F; McCombie, Stuart W; Tagat, Jayaram R; McKittrick, Brian A; Baroudy, Bahige M; Gilbert, Eric; Clader, John W; Neustadt, Bernard R; Labroli, Marc A; Palani, Anandan

Agent Griffith Hack

Pub. Number AU-B-2005202357

Parent 780888

Filing date 31 May 2005

Wipo publication date 23 June 2005

Acceptance publication date 2 April 2009

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

16 June 2005 Complete Application Filed

23 June 2005 Application Open to Public Inspection

  Published as AU-B-2005202357

2 April 2009 Application Accepted

  Published as AU-B-2005202357

30 July 2009 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202358-Piperidine derivatives useful as CCR5 antagonists

2005202356-Frame scattering for video scrubbing